(Q36087990)

12 August 2017

Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants (English)

1 reference

12 August 2017

0 references

R Preston Mason

1

1 reference

12 August 2017

Robert F Jacob

2

1 reference

12 August 2017

Ruslan Kubant

3

1 reference

12 August 2017

Adam Jacoby

4

1 reference

12 August 2017

Febee Louka

5

1 reference

12 August 2017

J Jose Corbalan

6

1 reference

12 August 2017

Tadeusz Malinski

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

British Journal of Clinical Pharmacology

12 August 2017

1 reference

12 August 2017

74

1 reference

12 August 2017

1

1 reference

12 August 2017

141-146

1 reference

Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394138

Targeting nitric oxide with drug therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394138

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394138

Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394138

Endothelial dysfunction in human disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394138

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394138

Role of endothelium-derived nitric oxide in the regulation of blood pressure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394138

Endothelial function in chronic congestive heart failure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394138

Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394138

Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394138

Effect of AT1 receptor blockade on endothelial function in essential hypertension

11 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Angiotensin Subtype 1 Receptor (AT1) Blockade Improves Vasorelaxation in Heart Failure by Up-Regulation of Endothelial Nitric-Oxide Synthase via Activation of the AT2Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Endothelial nitric oxide synthase gene is positively associated with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Nitric oxide synthase gene polymorphism (G894T) influences arterial stiffness in adults: The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04189.X

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

21 January 2018

1 reference

12 December 2020

Amperometric sensors for simultaneous superoxide and hydrogen peroxide detection

1 reference

12 December 2020

Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension

1 reference

12 December 2020

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis

1 reference

12 December 2020

Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans

1 reference

12 December 2020

10.1111/J.1365-2125.2012.04189.X

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22283728

1 reference